SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001274644-17-000070
Filing Date
2017-09-29
Accepted
2017-09-29 08:01:30
Documents
1
Period of Report
2017-09-28
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K - APPROVAL OF APPLICATION TO NASDAQ CAPITAL MARKET ocera-8xkapprovalofapplica.htm 8-K 26383
  Complete submission text file 0001274644-17-000070.txt   27621
Mailing Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065
Business Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065 6504750158
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 171109046
SIC: 2834 Pharmaceutical Preparations